Check-Cap Ltd. (CHEK:NASDAQ) closed at $1.61 on November 26, 2025, up 1.90% on the day. The stock trades 48.6% below its 52-week high of $3.13 and 187.5% above its 52-week low of $0.560. Check-Cap Ltd. is part of the Health Care sector (Medical Electronics).
In 252 trading sessions since October 23, 2025, CHEK closed higher on 14 days (6%). Its best day was November 7, 2025 (+37.19%) and its worst was November 18, 2025 (-15.59%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 1 time.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. The company was founded in 2004 and is based in Isfiya, Israel.
Find more stocks like CHEK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.